Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Alan Colowick | Director | 2025-04-02 | 2,300 | $7.49 | $17.24kBuy |
Martin Babler | President CEO and Chairman | 2025-04-01 | 15,650 | $6.44 | $100.74kBuy |
Alan Colowick | Director | 2025-04-01 | 16,104 | $6.97 | $112.31kBuy |
Foresite Capital Management V LLC | 10% Owner | 2024-07-01 | 312,500 | $16.00 | $5.00MBuy |
Foresite Labs LLC | 10% Owner | 2024-07-01 | 2,187,500 | $16.00 | $35.00MBuy |
Foresite Labs LLC | 10% Owner | 2024-07-01 | 312,500 | $16.00 | $5.00MBuy |
James B. Tananbaum | Director | 2024-07-01 | 2,187,500 | $16.00 | $35.00MBuy |
Srinivas Akkaraju | Director | 2024-07-01 | 1,562,500 | $16.00 | $25.00MBuy |
James B. Tananbaum | Director | 2024-07-01 | 312,500 | $16.00 | $5.00MBuy |
Ayurmaya Capital Management Company LP | Director | 2024-07-01 | 2,500,000 | $16.00 | $40.00MBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ayurmaya Capital Management Company LP | 19.57% | 10,645,966 | $53.23M | Insider |
Ayurmaya Capital Management Company LP | 19.57% | 10,645,966 | $53.23M | Institution |
Foresite Capital Management V LLC | 10.62% | 5,779,348 | $28.90M | Institution |
Foresite Capital Management VI LLC | 7.72% | 4,202,670 | $21.01M | Institution |
Srinivas Akkaraju | 6.00% | 3,266,498 | $16.33M | Insider |
Samsara Biocapital LLC | 6.00% | 3,266,498 | $16.33M | Institution |
Venbio Partners LLC | 5.12% | 2,787,398 | $13.94M | Institution |
Cormorant Asset Management LP | 3.95% | 2,147,396 | $10.74M | Institution |
Sr One Capital Management LP | 3.60% | 1,959,896 | $9.80M | Institution |
Baker Bros Advisors LP | 2.87% | 1,562,500 | $7.81M | Institution |